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Two clinical isolates of Mycoplasma hyosynoviae showed 
differing pattern of lameness and pathogen detection in 
experimentally challenged pigs
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Erin L. Strait1,4, Everett L. Rosey5, Vicki J. Rapp-Gabrielson5
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3Wisconsin National Primate Research Center, University of Wisconsin, Madison, WI 53703, USA
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Mycoplasma (M.) hyosynoviae is known to colonize and cause disease in growing-finishing pigs. In this study, two clinical isolates of M. 
hyosynoviae were compared by inoculating cesarean-derived colostrum-deprived and specific-pathogen-free growing pigs. After intranasal 
or intravenous inoculation, the proportion and distribution pattern of clinical cases was compared in addition to the severity of lameness. 
Tonsils were found to be the primary site of colonization, while bacteremia was rarely detected prior to the observation of clinical signs. 
Regardless of the clinical isolate, route of inoculation, or volume of inocula, histopathological alterations and tissue invasion were detected 
in multiple joints, indicating an apparent lack of specific joint tropism. Acute disease was primarily observed 7 to 10 days post-inoculation. 
The variability in the severity of synovial microscopic lesions and pathogen detection in joint cavities suggests that the duration of joint 
infection may influence the diagnostic accuracy. In summary, these findings demonstrate that diagnosis of M. hyosynoviae-associated arthritis 
can be influenced by the clinical isolate, and provides a study platform to investigate the colonization and virulence potential of field isolates. 
This approach can be particularly relevant to auxiliate in surveillance and testing of therapeutic and/or vaccine candidates. 
Keywords: Mycoplasma hyosynoviae, arthritis, lameness, swine
Introduction
Mycoplasma (M.) hyosynoviae is known for causing non- 
purulent arthritis in growing pigs [16,22], and its ubiquitous 
nature in pig populations [11,22]. Pigs of all ages are believed to 
be susceptible to colonization [10,12]. Sows are presumably the 
primary infectious reservoir, and piglets can become colonized 
prior to weaning, or by horizontal transmission post-weaning 
[8,17]. Upon colonization, M. hyosynoviae can persist in the 
tonsils and animals may become life-long carriers [2,17]. 
Bacteremia occurs in a subset of susceptible pigs, and has been 
shown to precede clinical disease [7]. Although the disease risk 
factors are not fully understood, M. hyosynoviae-associated 
arthritis is often reported to occur upon exposure to environmental 
stressors such as temperature fluctuation, increased stocking 
density, and commingling of non-litter mates [15]. However, 
the virulence determinants and host pathways that converge to 
the occurrence of the disease phenotype typically seen in field 
cases are still not understood [1,11]. Although M. hyosynoviae- 
associated disease has been experimentally reproduced before 
[7,12,18], this study was conducted to determine if distinct 
clinical isolates could have different disease phenotypes, and 
which inoculation route and infectious dose combination would 
be more robust to reproduce them. Additionally, multiple 
diagnostic specimens were tested for the presence of M. 
hyosynoviae and induced histological alterations to determine 
the optimal criteria for clinical diagnosis. 
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Materials and Methods
Two clinical isolates obtained from temporally, spatially, and 
herd-source differing field cases (diagnosed by the Iowa State 
University Veterinary Diagnostic Laboratory; ISU-VDL) of pig 
M. hyosynoviae-associated arthritis (i.e., 3491 and 3496) were 
used to challenge pigs intranasally (IN) or intravenously (IV). 
Pigs inoculated IN with isolate 3491 received either 5 mL (n = 
5 per group) or 10 mL (n = 5 per group), while all pigs inoculated 
IN with isolate 3496 received 10 mL (n = 5 per group). Animals 
inoculated IV received 2 mL of either 3491 (n = 11) or 3496 
(n = 7). Control animals (n = 4) received the same medium used 
to grow this bacterium either IN (n = 3) or IV (n = 1). For this 
study, six to twelve week old cesarean-derived colostrum-deprived 
(CDCD) specific-pathogen-free (SPF) pigs were acquired from 
a herd known to be free of all major swine mycoplasmas 
including, M. hyopneumoniae, M. hyosynoviae, M. hyorhinis, 
and M. flocculare, as determined by serology and species-specific 
conventional or quantitative polymerase chain reaction assays 
(qPCR) of nasal swab and tonsil scraping fluid samples from all 
experimental animals [3,5,21]. The pigs were housed in a 
BSL-2 facility at the ISU-VDL and all husbandry procedures 
were carried out following routine SPF facility biosecurity 
protocols to prevent cross-contamination. Pigs were fed 
commercial feed with no antibiotics (Nature’s Made; 
Heartland, USA). Prior to M. hyosynoviae inoculation, all pigs 
were treated intramuscularly with 2 mL of ceftiofur sodium 
(Excede; Zoetis, USA) to prevent post-arrival infection with 
any other bacteria. All animal experimental protocols were 
approved by Iowa State University’s Institutional Care and Use 
Committee.
Inoculum preparation and animal inoculation
Culture of M. hyosynoviae was carried out using previously 
described protocols [18,20]. The two clinical isolates used 
herein were isolated from clinical specimens known to be 
devoid of any other major swine bacterial and viral pathogens 
by the ISU-VDL (i.e., Haemophilus parasuis, Streptococcus 
suis, M. hyorhinis, Salmonella spp., Erysipelothrix rhusiopathiae, 
Porcine circovirus, and Porcine reproductive and respiratory 
syndrome virus). For isolation, a 1 : 10 ratio of filtered joint 
fluids from selected clinical specimens were inoculated into 
Difco pleuropneumonia like organism (PPLO) (Difco; BD 
Biosciences, USA) based media with turkey serum (15%) and 
mucin from porcine stomach (5%) broth and incubated at 37oC 
for 3 to 7 days. After the initial culture, an aliquot of culture 
fluid was tested for the presence of M. hyosynoviae by qPCR 
[3]. To confirm the absence of contaminating bacteria, routine 
aerobic culture for non-mycoplasma species was also performed 
using both chocolate agar and blood agar plates. To develop 
challenge material, 1 mL of frozen stock of each isolate was 
adapted to Difco PPLO media supplemented with 15% 
heat-inactivated horse serum (Donor Horse Serum; Atlanta 
Biologicals, USA), termed Difco horse sera (DHS). All sera 
utilized throughout the study were heat inactivated at 56oC (via 
water bath) for 30 min prior to use. Media was mixed and pH 
adjusted to 7.4 (via 1N HCl or 1N NaOH) before being 0.22 m 
filtered and placed at 37oC for 48 h to check for contamination 
by visual inspection for turbidity. Each media was then 
aliquoted into 1.8 mL in 30 tubes to set up a ten-fold serial 
dilution series in triplicate. Frozen stock M. hyosynoviae 
cultures at passage 2 (p2), 3491 and 3496, were thawed at room 
temperature, after which 0.5 mL was used to inoculate 5 mL of 
D-TS. Prior to DHS inoculation, Difco Turkey Serum was used 
for the initial passage to ensure growth from frozen stock. 
Following 24 h of incubation at 37oC, 0.2 mL of p3 were serially 
diluted into DHS and incubated. The challenge inocula were 
prepared in Difco PPLO media supplemented with 15% 
heat-inactivated horse serum (Donor Horse Serum; Atlanta 
Biologicals) to prevent anaphylaxis. To prepare challenge 
material, 1 mL of each DHS-adapted isolate was passed into 5 
mL of fresh DHS, after which a final inoculum was passed into 
25 mL of media for challenge administration. A 100 L (10−1 
dilution) sample was subsequently spread plated onto blood and 
chocolate agar plates for purity verification. Next, 10 L (10−2 
dilution) was plated onto brain heart infusion (BHI) agar plates 
to confirm mycoplasma growth by morphology. All plating was 
performed in triplicate throughout the experiment. Quantification 
of all inocula, as per color-changing unit-CCU per mL, was 
performed by dilution plating on DHS agar plates and 
inoculating broth [20]. Color-changing units per mL were 
calculated using arginine and phenol red, and a total of 1010 
CCU per mL was used for IV and IN inoculation upon restraining 
all animals as previously described [7,20]. For inoculation, 
animals were restrained with a snare as previously described 
[10]. Despite the route and volume of inoculum administered, a 
1010 CCU per mL of either isolate was used. IV inoculation was 
carried out using a butterfly catheter in an ear vein; whereas, for 
IN administration half of the inoculum was placed into each 
nostril using a sterile syringe [7,18]. 
Clinical observations and in vivo sampling
Pigs were clinically monitored prior to and after inoculation 
for any clinical signs, particularly lameness. A single evaluator 
collected all observations throughout the study to ensure 
consistency. Lameness was scored from 0 to 3 (from slightly to 
severe clinical signs) as previously described [12]. Whole 
blood, nasal swabs, and tonsil scraping samples were collected 
prior to inoculation, and every 2 to 3 days post-inoculation (dpi) 
until necropsy. A fraction of all blood samples was then 
centrifuged at 2,000 × g for 10 min, after which serum was 
aliquoted into 5 mL tubes (BD Falcon; BD Biosciences, USA). 
Whole blood was collected using a 10 mL EDTA (K2) tube (BD 
Vacutainer; BD Diagnostics, USA). Nasal swabs were collected 
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using a single 15 cm sterile nylon flocked swab (Puritan; 
Puritan Medical Products, USA) sampling both nares each 
time, and placed into 5 mL polystyrene round bottom snap-cap 
tubes (BD Falcon; BD Biosciences) containing 2 mL of 1× 
sterile phosphate buffer saline solution (PBS; Invitrogen, 
USA). Tonsil scrapings were collected by holding the mouth 
open with a sterilized oral speculum and scraping the surface of 
the tonsil using a sterilized, blunt stainless steel spoon with an 
elongated handle [23]. Tonsil scraping contents were then 
collected from the steel spoon using a 15 cm sterile nylon swab 
(Puritan; Puritan Medical Products) and placed into 5 mL tubes 
(BD Falcon; BD Biosciences) containing 3 mL of sterile 1× 
PBS. All samples were stored at −20oC until assayed.
DNA extraction and quantitative PCR
DNA extraction was performed using magnetic beads 
(MagMAX Total Nucleic Acid Isolation Kit; Applied 
Biosystems, USA) in a semi-automatic system (KingFisher 96 
Magnetic Particle Processor; Thermo Fisher Scientific, USA) 
according to the manufacturer’s instructions, after which 
samples were frozen at −20oC until assayed for M. hyosynoviae 
by qPCR [3]. All clinical specimens including nasal swab, 
whole blood, serum, tonsil scraping, and synovial fluids or 
swabs were tested in duplicate for M. hyosynoviae by qPCR 
[3,5,19]. qPCR was also used to detect the presence (1) or 
absence (0), and to determine the M. hyosynoviae load per 2.5 
L of blood, serum, and joint samples [3].
Necropsy and histopathology
Euthanasia was performed by administering a barbiturate 
overdose (Fatal-Plus; Vortech Pharmaceuticals, USA) via IV 
injection. At 12, 14 or 15 dpi, animals were necropsied, and the 
following joint cavities were sampled: scapula-humeral, 
humero-radial, coxi-femoral, femoro-tibial, and tibio-tarsal 
from the right and left side of each animal. Joint fluids or swabs 
were aseptically collected for M. hyosynoviae qPCR. Synovium 
tissues were placed into a 10% buffered formalin solution for 
histopathology evaluation. In addition, tonsil tissues were 
collected and ground in 10 mL of 1× PBS for M. hyosynoviae 
qPCR detection. Joint fluids were also plated on blood agar, 
chocolate agar, and BHI, and were cultivated aerobically at 
37oC for 3 to 5 days to check for extraneous bacterial growth. 
The histopathology scoring used was modified from a 
previously described method [6]. Histopathology scores for 
each sample were combined to provide a composite inflammatory 
score ranging from 0 to 15. Scoring was conducted by a board 
certified veterinary pathologist who was blinded to all 
treatments. 
Statistical analysis
Statistical analysis of the data was performed using the 
GraphPad Prism 6 (GraphPad Software, USA) and MedCalc 
15.6 (MedCalc Software, Belgium). Descriptive analysis was 
initially conducted to assess the overall quality of the data. The 
proportion of clinical cases, degree of lameness cases, and 
qPCR positive joints per group, were analyzed using a 
Chi-squared test (GraphPad Prism 6). One-way ANOVA was 
used to compare the percentage of clinical cases across 
treatments over time. Histopathology scoring was analyzed 
using a non-parametric one-way ANOVA (Kruskal-Wallis) 
followed by multiple group comparison using Dunn’s test. The 
significant level across all analyses was based on a p ＜ 0.05. 
Receiving operating characteristic curve analysis was used to 
determine the cut-off point for the histopathology score to 
differentiate diseased vs. non-diseased animals using MedCalc 
15.6. After establishing the cut-off, the histopathology results 
were converted to a binary variable, with 0 indicating joints 
below the threshold histopathology score threshold of 1, and 1 
indicating all other values. It should be noted that the binary 
value of 1 is different than the histological score of 1. It simply 
happens that the threshold established for the microscopic 
alteration equals 1. This was justified based on the microscopic 
score of 0 for all joints in the control group and the score of 1 in 
the disease group being a morphological alteration typically 
found in M. hyosynoviae infected animals (i.e., synovial cell 
proliferation). The qPCR test results were also interpreted as 
negative (0) or positive (1) [3]. The combination of both metrics 
(i.e., histopathology and qPCR) was then used to verify the odds 
ratio-OR to predict clinical disease. The OR was subsequently 
analyzed using a 95% confidence interval, which implies that if 
the value of 1 is included in this interval, there is absence of 




All pigs used in the study were clinically healthy prior to 
challenge. Anaphylaxis did not occur upon inoculation. 
Lameness was clinically evident post challenge; however, it 
varied in severity in pigs from each inoculation group, 
regardless of isolate, volume, or route of inoculation (Fig. 1). 
Overall, a higher proportion of cases was observed in animals 
inoculated with isolate 3491 vs. 3496, with disease developing 
more rapidly upon IV inoculation. IN inoculation also led to 
robustness in the development clinical disease when using 10 
mL of inocula. A significantly higher proportion of cases and 
longer duration of lameness were observed for isolate 3491 vs. 
3496. Due to limited availability of CDCD-SPF pigs, the 5 mL 
volume for IN was only assessed for isolate 3491. A significantly 
higher mean lameness score was observed for animals 
inoculated IN with 10 mL of isolate 3491 compared to 5 mL, 
and this was greater than IV administration (Fig. 2). Overall, 
only mild lameness was observed for isolate 3496, despite the 
492    João Carlos Gomes-Neto et al.
Journal of Veterinary Science
Fig. 1. Distribution of experimentally induced Mycoplasma (M.) 
hyosynoviae- associated clinical cases. Clinical observations 
were collected daily from 0 to necropsy across all groups. A 
Chi-squared test was used to compare the distribution of clinical
cases (p ＜ 0.05). Overall, a higher percentage of cases was seen
in animals inoculated with isolate 3491 than 3496. The 
intravenous (IV) route led to a more rapid development of 
clinical signs compared to intranasal (IN) injection. Moreover, IV
and 10 mL inoculation with isolate 3491 led to longer duration 
of clinical disease than 3496 (p ＜ 0.05). The results for the 
negative control group are not depicted above since there was a
complete absence of clinical cases for those animals. 
Fig. 2. Mean lameness score (mean + SEM) across M. hyosynoviae
inoculated groups. All observations were taken daily from 0 to 
necropsy. The clinical lameness scoring system varied from 0 to 
3 corresponding to no lameness, slight, moderate, or severe 
clinical signs. The Chi-squared and the Friedman’s tests were 
used to compare the distribution of severity of cases across 
groups (p ＜ 0.05). A significantly higher mean lameness score 
was observed for animals inoculated IN with 10 mL of isolate 
3491 than for all other groups between 10 to 14 (p ＜ 0.05). 
Results for the negative control group are not shown because of 
the lack of clinical lameness for those animals. 
Fig. 3. Percentage of quantitative polymerase chain reaction 
assays (qPCR) positive joints for M. hyosynoviae by isolate, 
individually or combined. Overall, a higher percentage of qPCR
positive samples was found in all cases for two anatomical 
locations: the humero-radial and coxi-femoral joint. However, a
broad distribution of this pathogen is seen given that at least 30%
of any given joint sample tested positive for the organism. The 
control group was not included here since none of the joint 
samples in that group tested positive for M. hyosynoviae by 
qPCR. 
Fig. 4. Distribution of the percentage of M. hyosynoviae qPCR 
positive joints by isolate and anatomical location. Significant 
differences in the proportion of M. hyosynoviae tested positive 
joints were found when comparing across inoculated groups by 
anatomical location. Asterisks mark the inoculated groups 
(isolate and/or volume of inocula) that differ significantly for each 
joint cavity (p ＜ 0.05). A higher percentage of M. hyosynoviae
positive joints was found for the following groups: 5 mL IN 3491,
10 mL IN 3491, and 10 mL IN 3496 for the humero-radial joint, 
2 mL IV 3491 and 3496 for the coxi-femoral joint, and 2 mL IV
3496 for the femoro-tibial joint compared to other challenged 
and control groups (p ＜ 0.05). Data for the control group are not
depicted due to the absence of detection for this bacterium. 
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Fig. 5. Box-plot whiskers depicting the comparative analysis of M. hyosynoviae microscopic alterations by joint cavity. Histopathology 
scores (ranging from minimum to maximum) are depicted across all panels. (A) Scapulo-humeral joints. (B) Humero-radial joints. (C)
Coxi-femoral joints. (D) Femoro-radial joints. (E) Tibio-tarsal joints. Statistical analysis was conducted by comparing all groups using 
the non-parametric one-way ANOVA Kruskal-Wallis test followed by multiple comparisons with Dunn’s test. Different letters above
the box-plot whiskers data indicate significantly differences across groups (p ＜ 0.05).
inoculation route. 
M. hyosynoviae detection by qPCR 
At least 30% of the joints tested positive for M. hyosynoviae 
by qPCR at necropsy, regardless of the route of inoculation and 
isolate used in the challenged groups. Approximately 60% of all 
samples tested from two joints (humero-radial and coxi-femoral) 
were qPCR positive when combining data from all routes of 
inoculation for each isolate separately or together (Fig. 3). No 
significant differences were found when comparing either the 
proportion of M. hyosynoviae positive joints among anatomical 
location were observed within each inoculated group, or in the 
log10 bacterial load/2.5 L of sample among positive samples 
across groups (data not shown). Conversely, significant differences 
in the proportion of M. hyosynoviae positive joints were found 
when inoculated groups were compared within each anatomical 
location. Specifically, a higher proportion of positive samples 
was found for the following groups given in three joints: 5 mL 
IN 3491, 10 mL IN 3491, and 10 mL IN 3496 for the humero- 
radial joint (p = 0.0238); 2 mL IV 3491 and 3496 for the 
coxi-femoral joint (p = 0.025); and 2 mL IV 3496 for the 
femoro-tibial joint (p = 0.0115) compared to other challenged 
and control groups (Fig. 4). The tonsils of all inoculated animals 
were consistently positive for M. hyosynoviae; however, 
bacteremia was very rarely detected in whole blood or serum 
(data not shown). All control animals were negative for M. 
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Table 1. Odds ratio comparing diseased vs. non-diseased 






95% Confidence interval (CI)
Lower Upper
Scapulo-humeral 5.2 1.3 20.4
Humero-radial 2.4 0.8   7.0
Coxi-femoral 4.2 1.4 12.1
Femoro-tibial 1.0† 0.3†    2.7†
Tibio-tarsal 5.7 1.6   9.6
*Both qPCR and histopathological metrics were used as binary outcomes 
(i.e., 0 or 1), as part of the diagnostic criteria used to predict clinical disease 
post-exposure to M. hyosynoviae. The comparison was set to test the 
effects of the impact of having M. hyosynoviae in the joint in addition to a 
significantly altered microscopic score. OR and 95% CI are depicted for all 
joint cavities assessed in the study. The OR threshold of significance is 
equal to 1 since the presence of this value within the 95% CI indicates 
absence of differences in the ratio between diseased and non-diseased 
animals given the criterion of interest. †These values in the table indicate 
that both the humero-radial and femoro-tibial joints showed no significant 
difference between the diseased and non-diseased animals. 
hyosynoviae in the joint cavity, tonsils, blood, serum, and nasal 
cavity. No other bacteria were found in the joints of inoculated 
animals. 
Histopathology
All challenge groups had at least one joint that was 
significantly more affected than the control group. The 
coxi-femoral joint was most consistently more affected in the 
challenge group than the control group. Specifically, with the 
exception of the group receiving 10 mL IN of 3496, all 
challenged groups had significantly higher histopathological 
alterations in the coxi-femoral joint than the non-challenge 
group (Fig. 5). When combining the histopathological and 
qPCR findings into a diagnostic metric, a significantly higher 
likely of developing clinical disease vs. none was associated 
with being qPCR positive and having histopathological lesions 
in joints except for the femoro-tibial joint (Table 1). 
Discussion
Mycoplasma hyosynoviae is one of the major causative 
agents of arthritis in post-weaning pigs, particularly in 
growing-finishing animals, along with M. hyorhinis, and other 
bacteria such as Haemophilus parasuis, Streptococcus suis, 
Erysipelothrix rhusiopathiae, and Salmonella enterica serovar 
choleraesuis [4]. M. hyosynoviae induces a non-suppurative 
self-limiting lameness in growing-finishing pigs [22]. Because 
M. hyosynoviae-associated arthritis is considered a re-emerging 
problem in swine production, particularly in the United States 
[4], there is an increasing need to further investigate the 
epidemiology and pathobiology of the disease associated with 
it. While experimental induction of arthritis by this bacterium 
has previously been described by both intranasal and 
intramuscular inoculations [7,12,18], the present study was 
conducted to compare the robustness of such an experimental 
approach when varying the clinical isolate origin, route of 
inoculation, and volume of inocula. Additionally, sampling of 
multiple clinical specimens was conducted prior to and at 
necropsy in attempt to propose an optimal diagnostic approach 
for M. hyosynoviae detection and case confirmation. The 
pathogen detection was then compiled with the histopathological 
scoring to create a criterion to be used in defining the disease 
status of an infected animal. 
It is particularly important to mention that the use of 
CDCD-SPF pigs ensured experimental success in this setting. 
This approach prevented potential confounders such as the 
presence of cross-reactive antibodies with other swine 
mycoplasmas, as well as co-infections with other major swine 
pathogens from impacting the study outcome [5]. As age had 
been previously shown to not influence disease severity of M. 
hyosynoviae-associated arthritis, six to twelve week-old 
CDCD-SPF pigs were used in this study [12]. Following 
inoculation, and irrespective of the isolate, route, and volume of 
inocula, a high prevalence of animals tested positive for M. 
hyosynoviae in the tonsil, but not in the nasal cavity. Although 
this finding is not correlated with clinical outcome, it suggests 
that the tonsil might be the primary reservoir for long-term 
carriage [7,10,12]. Factors driving M. hyosynoviae tropism for 
the tonsil rather than the nasal cavity are currently unknown 
[1,11]. Given that long-term carriage in the tonsil is the likely 
source of joint infection via septicemia within an animal, it is 
possible that a source (tonsil)-and-sink (joint) infection 
dynamic could explain the infection process [9,14]. Although 
bacteremia was rarely in the whole blood or serum, as opposed 
to in previous studies [7], the absence of the pathogen from 
certain joints at necropsy supports this potential dynamic. 
Specifically, disease re-occurrence within an animal, or joint 
inflammation driven by this pathogen, would be dependent on 
multiple joint invasions from organisms from the tonsil. Even 
though this is an interesting association, it is yet to be 
experimentally demonstrated. Nonetheless, it is important to 
mention that, for epidemiological surveillance, tonsil sampling 
may be more effective than nasal swabbing. These findings also 
suggests that pen-based oral fluids can be effective in herd 
screening [3]. 
The comparison between the two M. hyosynoviae clinical 
isolates indicates that isolate 3491 is more virulent than 3496. 
The IV route tends to induce clinical disease faster than IN for 
both isolates, but to last for a shorter period than IN. That 
distinctive pattern of IV vs IN may be explained by how fast the 
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bacterial population can invade the joint tissue. However, the 
fact that clinical diseases show a more rapid decrease in 
prevalence and severity via the IV route than when using 10 mL 
of inocula IN indicates that the resolution of the inflammatory 
process is also more rapid for the former. This is an important 
finding because there are advantages and disadvantages for both 
routes of inoculation with respect to studying the pathogenesis of 
this bacterium. In particular, if one is interested in reproducing 
what is occurring in natural pig populations, the IN route would 
be more suitable given that horizontal transmission is thought to 
occur that way. However, depending on the isolate used, disease 
may not occur in high frequency or severity. Conversely, by 
inoculating via IV, the experimental approach may become 
more robust and facilitate screening for isolates capable of 
causing more severe disease since it bypasses the initial 
colonization step of the upper respiratory tract. Yet, more 
isolates would have to be tested to define the most optimal route 
and volume of inocula and to determine the genotype-phenotype 
correlation across M. hyosynoviae strains [7,13,22]. 
Although clear variations in distribution and severity of 
clinical cases were seen between isolates, the histopathology 
scores did not fully reflect these differences. This can be 
partially attributed to the variability in timing of the necropsy 
relative to the onset of clinical disease, in addition to the low or 
absent bacterial load in joints at necropsy. Despite the lack of 
specific joint tropism, the higher proportion of positivity, were 
seen for the humero-radial, coxi-femoral, and scapula-humeral 
joints. Combined, the qPCR and histopathological results 
suggest that their uselfuness for post-mortem diagnostics only 
comes when interpreted together as proposed in our diagnostic 
criterion. As suggested here, a cohesive diagnosis of M. 
hyosynoviae-associated arthritis should include the presence of 
the bacterium and typical morphological alterations of the 
synovia. In conclusion, this study demonstrated that clinical 
lameness caused by M. hyosynoviae can be reproduced by 
infecting CDCD pigs either IV or IN with no specific joint tissue 
tropism. However, the variability in disease phenotype, 
including pathogen detection and histopathological scoring, 
strengthens the idea that post-mortem diagnostic criterion has to 
be stringent to increase its accuracy. Moreover, given the 
demonstration that differing clinical isolates can have a distinct 
impact in clinical lameness, more comprehensives studies 
should be conducted with well-established collections of 
genotyped strains to determine the markers associated with 
virulence of this pathogen. 
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